
The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
PerkinElmer’s cannabis testing portfolio features best-in-class sample homogenization platforms, ICPMS, LCMSMS, Headspace-GCMS, UHPLC and FTIR instruments and consumables.





